About Intellectual Property IP Training IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars World IP Day WIPO Magazine Raising Awareness Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Enforcement Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO ALERT Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight

WIPO to Host Symposia on Life Sciences and IP

Geneva, August 30, 2007
MA/2007/31

The World Intellectual Property Organization (WIPO) is organizing a series of symposia in the coming months, at its Geneva headquarters, to clarify the intellectual property (IP) dimension in the life sciences. The symposia are addressed to a wide range of stakeholders, including international policymakers, government agencies, legislators, delegates, private sector and civil society actors. 

The first life sciences symposium on bioethics will be held on Tuesday, September 4, 2007. It will cover a wide range of ethical questions that arise in the debate over biotech IP rights:

(i)         What are the ethical aspects of a life sciences technology as such (e.g. should research on embryonic stem cells or human cloning be permitted)?
(ii)        What are the ethical aspects of a national authority granting exclusive IP rights over a technology (e.g. should patents be granted for DNA sequences or for genetically modified mammals)?
(iii)       What are the ethical aspects of an individual, a firm or an institution choosing to seek exclusive IP rights over a technology (e.g. should a publicly funded agency patent its research results on a new vaccine production technique)?
(iv)       What are the ethical aspects of how an IP right holder chooses to exercise its exclusive rights over a technology (e.g. should the holder of a patent over a basic research tool license it in a broad or restrictive way)?

The program and information on the full series of the WIPO Life Sciences Symposia is available at https://www.wipo.int/patentscope/en/lifesciences/. The event is free of charge and open to the general public. Anyone interested in attending the meeting is requested to complete the on-line registration form at https://www.wipo.int/meetings/en/2007/lifesciences/sym_bioethics/registration.html.

For more information, please contact the News and Media Division at WIPO:
  • Tel: (+41 22) 338 81 61 / 338 72 24
  • E-mail
https://www3.wipo.int/contact/en/area.jsp?area=publicinfo https://www.wipo.int/pressroom/en/ https://www.wipo.int/tools/en/disclaim.html https://www.wipo.int/en/web/privacy-policy/ https://www.wipo.int/en/web/accessibility/ https://www.wipo.int/tools/en/sitemap.html https://www3.wipo.int/newsletters/en/ https://www.wipo.int/podcasts/en/ https://www.wipo.int/news/en/